Brevia Health deepens vaccines expertise with Nick Lowen appointment

Brevia Health has deepened our vaccines expertise with the appointment of Nick Lowen as an Associate with over 30 years’ life sciences experience including serving as Vice President, Commercial Strategic Projects at GSK.  During his time at GSK, Nick successfully led complex negotiations including the introduction of innovative vaccines for the UK and other European markets.  As Vice Chair of the UK Industry Vaccines Group, he oversaw the development of the ABPI position on market access and response to the DHSC CEMIPP report.  Nick joins our senior team of advisers that include Gillian Leng CBE (former CEO, NICE), Jonathan Mogford (former Director of Policy, MHRA) and Mike Thompson MBE (former CEO, ABPI).

Nick trained as a pharmacist and began his career in the NHS.  Before joining the Biopharma industry, he was one of the UK’s first regional NHS Pharmaceutical advisers.

He joined GSK in 1997 where he worked for over 25 years and held a number of senior leadership roles.  During this period, he successfully led complex negotiations including the introduction of innovative vaccines for the UK and other European markets.  As Vice Chair of the UK Industry Vaccines Group, Nick oversaw the development of the ABPI position on market access and response to the DHSC CEMIPP report.

In addition to Vaccines, Nick has therapeutic experience in Neurology, Dermatology, Anti-infectives, Respiratory, Oncology and specialist medicines.

Nick has a passion for delivering marketing and sales excellence across Global, EU and UK Pharmaceutical markets through launching innovative products, life cycle management and building market access.  He has a strong track record managing teams to create and deliver strategic business change in Pharma, including managing the transition to outsource operations in multiple countries, creating business development opportunities, and negotiating and concluding significant business deals.

 

BREVIA HEALTH PROVIDES STRAIGHTFOWARD PUBLIC AFFAIRS AND PUBLIC RELATIONS SUPPORT TO BUSINESSES AND CHARITIES OPERATING IN THE HIGHLY REGULATED UK HEALTHCARE SECTOR

Discover how Brevia can help you and your organisation by viewing our Health services or contacting the Brevia Team on 020 7091 1650 or emailing us at contact@brevia.co.uk

 

 

 

 

 

LATEST NEWS

Energy

What does Miatta Fahnbulleh MP need from Allocation Round 8?

On 20 July, the application window for Allocation Round 8 (AR8) opened, the third renewable auction under a Labour Government, which will have a critical role in realising its energy policy ambitions. The opening coincided with Miatta Fahnbulleh MP’s appointment as the new Secretary of State for the Department of Energy Security and Net Zero (DESNZ).

Read More »
Energy

DIP-ping into the DESNZ budget

The outgoing Prime Minister has confirmed that funding the Defence Investment Plan (DIP) will require capital projects in roads and energy to be scrapped. On top of the 1% reduction in capital budgets that all Departments must find to fund the DIP, DESNZ will be tasked with finding a further £2bn savings over four years.  For DESNZ this means a £100m capital budget reduction this calendar year, £600m in 2027/28, £700m in 2028/29, and £600m in 2029/30.  This article explores where these savings might come and potential impact on DESNZ commitments.   

Read More »